Oncolytics Biotech, Inc. (ONCY)
0.847
-0.01
(-1.01%)
USD |
NASDAQ |
Aug 27, 11:28
Oncolytics Biotech Total Return Level : 0.8556 for Aug. 26, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 26, 2026 | 0.8556 |
| August 25, 2026 | 0.8614 |
| August 24, 2026 | 0.8441 |
| August 21, 2026 | 0.8431 |
| August 20, 2026 | 0.8017 |
| August 19, 2026 | 0.831 |
| August 18, 2026 | 0.8448 |
| August 17, 2026 | 0.8227 |
| August 14, 2026 | 0.834 |
| August 13, 2026 | 0.80 |
| August 12, 2026 | 0.8237 |
| August 11, 2026 | 0.82 |
| August 10, 2026 | 0.8028 |
| August 07, 2026 | 0.8025 |
| August 06, 2026 | 0.8006 |
| August 05, 2026 | 0.7972 |
| August 04, 2026 | 0.8105 |
| August 03, 2026 | 0.775 |
| July 31, 2026 | 0.7533 |
| July 30, 2026 | 0.753 |
| July 29, 2026 | 0.7516 |
| July 28, 2026 | 0.7921 |
| July 27, 2026 | 0.8001 |
| July 24, 2026 | 0.8122 |
| July 23, 2026 | 0.8483 |
| Date | Value |
|---|---|
| July 22, 2026 | 0.8276 |
| July 21, 2026 | 0.8585 |
| July 20, 2026 | 0.85 |
| July 17, 2026 | 0.8533 |
| July 16, 2026 | 0.8831 |
| July 15, 2026 | 0.904 |
| July 14, 2026 | 0.9082 |
| July 13, 2026 | 0.9289 |
| July 10, 2026 | 0.8873 |
| July 09, 2026 | 0.92 |
| July 08, 2026 | 0.7923 |
| July 07, 2026 | 0.8558 |
| July 06, 2026 | 0.8802 |
| July 02, 2026 | 0.8991 |
| July 01, 2026 | 0.9007 |
| June 30, 2026 | 0.9499 |
| June 29, 2026 | 0.9615 |
| June 26, 2026 | 0.9478 |
| June 25, 2026 | 0.9203 |
| June 24, 2026 | 0.9215 |
| June 23, 2026 | 0.9409 |
| June 22, 2026 | 0.9172 |
| June 18, 2026 | 0.96 |
| June 17, 2026 | 0.9318 |
| June 16, 2026 | 0.9495 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 89.12 |
| Sangamo Therapeutics, Inc. | 0.1505 |
| Sarepta Therapeutics, Inc. | 19.46 |
| Anixa Biosciences, Inc. | 3.605 |
| Vicapsys Life Sciences, Inc. | 1.45 |